CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma

ABSTRACT Hepatocellular carcinoma (HCC) undergoes profound metabolic reprogramming, yet the specific lipid species responsible for driving immunosuppressive remodelling remain unclear. BODIPY 493/503 and Oil Red O staining were used to assess the lipid accumulation in macrophages treated with tumour‐conditioned medium. Immunofluorescence analysis was performed to visualize lipid droplets, while qPCR and flow cytometry were conducted to evaluate the expression of CD36, CD163, CD206 and PD‐L1 on macrophages. Transmission electron microscopy assay was applied to observe mitochondrial morphology and fission. Fatty acid screening was performed to identify the CD36‐mediated signalling pathway. In vivo validation was performed using a DEN/CCl 4 ‐induced HCC mouse model treated with oleic acid alone or in combination with the CD36 inhibitor SSO. We demonstrate that lipid‐rich conditioned medium from HCC cells (HCC‐CM) promotes CD36‐associated intracellular lipid accumulation in tumour‐associated macrophages (TAMs). This lipid accumulation drives M2 polarization, mitochondrial fission and upregulation of PD‐L1 expression in TAMs and is associated with impaired CD8 + T‐cell effector function. Among six representative fatty acids screened, oleic acid emerged as the strongest candidate and recapitulated these effects through CD36‐dependent lipid uptake, mitochondrial remodelling and PD‐L1 upregulation. SSO co‐treatment attenuated these effects both in vitro and in a DEN/CCl 4 ‐induced primary liver cancer model, where it was associated with improved CD8 + T‐cell effector function and reduced tumour growth. Our findings identify oleic acid as a key lipid mediator in TAM reprogramming and highlight CD36 as a potential therapeutic target to restore antitumour immunity in HCC.

Authors

Institutions

Publication Details

Journal
Immunology
Published
2026-11-15
DOI
https://doi.org/10.1111/imm.70233
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma

Qiuju Han, Mei Liu, Jian Zhang, Huajun Zhao et al.
Immunology
Immune cells in cancer
article

CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma

Qiuju Han, Mei Liu, Jian Zhang, Huajun Zhao, Lizhi Shi, Chenxin Huo, Haohao Li, Xinggang Lin, Menghua Li
article en

Abstract

ABSTRACT Hepatocellular carcinoma (HCC) undergoes profound metabolic reprogramming, yet the specific lipid species responsible for driving immunosuppressive remodelling remain unclear. BODIPY 493/503 and Oil Red O staining were used to assess the lipid accumulation in macrophages treated with tumour‐conditioned medium. Immunofluorescence analysis was performed to visualize lipid droplets, while qPCR and flow cytometry were conducted to evaluate the expression of CD36, CD163, CD206 and PD‐L1 on macrophages. Transmission electron microscopy assay was applied to observe mitochondrial morphology and fission. Fatty acid screening was performed to identify the CD36‐mediated signalling pathway. In vivo validation was performed using a DEN/CCl 4 ‐induced HCC mouse model treated with oleic acid alone or in combination with the CD36 inhibitor SSO. We demonstrate that lipid‐rich conditioned medium from HCC cells (HCC‐CM) promotes CD36‐associated intracellular lipid accumulation in tumour‐associated macrophages (TAMs). This lipid accumulation drives M2 polarization, mitochondrial fission and upregulation of PD‐L1 expression in TAMs and is associated with impaired CD8 + T‐cell effector function. Among six representative fatty acids screened, oleic acid emerged as the strongest candidate and recapitulated these effects through CD36‐dependent lipid uptake, mitochondrial remodelling and PD‐L1 upregulation. SSO co‐treatment attenuated these effects both in vitro and in a DEN/CCl 4 ‐induced primary liver cancer model, where it was associated with improved CD8 + T‐cell effector function and reduced tumour growth. Our findings identify oleic acid as a key lipid mediator in TAM reprogramming and highlight CD36 as a potential therapeutic target to restore antitumour immunity in HCC.

Immunology
Shandong University (CN)
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon